C-MER Medical Holdings Limited (stock code: 03309) reported that its authorized share capital remained at 8,000,000,000 ordinary shares, each with a par value of HKD 0.10, resulting in a total of HKD 800,000,000 as of October 31, 2025.

The total issued share count stayed at 1,255,560,870, while the balance of issued shares (excluding treasury) shifted from 1,244,992,870 to 1,241,516,870. Over the same period, treasury shares increased from 10,568,000 to 14,044,000. According to the announcement, these changes were primarily due to the repurchase of 3,476,000 shares, which were transferred to treasury.

Regarding the Post-IPO Share Option Scheme, 200,000 share options remained outstanding and unexercised, each with an exercise price of HKD 7.73. The announcement also noted that 23,218,000 shares had been repurchased for cancellation but had not yet been canceled at the end of October, while an additional 14,044,000 shares had been repurchased and recorded as treasury shares. The total repurchased amounts and share option details remained consistent with prior disclosures.